Patent ID: 9402864
Filing Date: 2016-08-02
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating iron deficiency in a human patient comprising swallowing one or more immediate release solid oral dosage forms comprising a delivery agent and an iron compound, wherein the weight ratio of iron compound to the delivery agent is from about 2:1 to about 1:700, and wherein the delivery agent is selected from N-[8-(2-hydroxybenzoyl)amino]caprylic acid, N-(10-[2-hydroxybenzoyl]amino)decanoic acid, N-(8-[2-hydroxy-5-chlorobenzoyl]-amino)octanoic acid, 4-[(2-hydroxy-4-chloro-benzoyl)-amino]butanoic acid, 8-(2-hydroxyphenoxy)octyldiethanolamine, 8-(N-2-hydroxy-4-methoxybenzoyl)aminocaprylic acid, 3-toluoxybutanoic acid, and pharmaceutically salts thereof.